Trial intelligence / Profile preview

Imatinib + Vinorelbine in Advanced Breast Cancer

NCT00372476Phase 4Completed

Sponsor
Novartis
Start
Jun 2006
Primary completion
Jul 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of imatinib in breast cancer, sponsored by Novartis. Started Jun 2006; status: completed.

02

Drugs

03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT00372476.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00372476.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call